Lifeloc Technologies, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020
August 14, 2020 at 02:26 am IST
Share
Lifeloc Technologies, Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced total revenue was USD 1.320 million compared to USD 2.337 million a year ago. Operating loss was USD 453,237 compared to operating Income of USD 300,608 a year ago. Net loss was USD 349,592 compared to net income of USD 218,720 a year ago. Basic loss per share from continuing operations was USD 0.14 compared to basic earnings per share from continuing operations of USD 0.09 a year ago. For the half year, total revenue was USD 3.338 million compared to USD 4.406 million a year ago. Operating loss was USD 655,509 compared to operating Income of USD 345,453 a year ago. Net loss was USD 514,898 compared to net income of USD 249,684 a year ago. Basic loss per share from continuing operations was USD 0.2 compared to basic earnings per share from continuing operations of USD 0.1 a year ago.
Lifeloc Technologies, Inc. is a manufacturer of evidential breath alcohol testers and related training and supplies for workplace, law enforcement, corrections, and international customers. The Company designs, produces and sells fuel-cell based breath alcohol testing equipment. It operates through two segments: Products and Rentals. The Products segment is engaged in the sale of physical products, including portable hand-held breathalyzers and related accessories, supplies, education, training, and royalties from development contracts with original equipment manufacturers (OEMs). The Rentals segment is engaged in the rental of a portion of its building. In addition, the Company offers a line of supplies, accessories, services, and training to support customers alcohol testing programs. It sells globally through distributors as well as directly to users. It sells certain of its components to customers for incorporation into their own product lines and for resale under their own name.